Anti-tumor natural killer cells are induced by herpes simplex virus thymidine kinase gene transduction and ganciclovir therapy in a mouse model of prostate cancer.

被引：0
|
作者：
Atkinson, G
Sanford, MA
Zaslau, S
Chen, SH
Hall, SJ
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
29
引用
收藏
页码：8 / 8
页数：1
相关论文
共 50 条
  • [41] GENE-THERAPY FOR THE TREATMENT OF RECURRENT PEDIATRIC MALIGNANT ASTROCYTOMAS WITH IN-VIVO TUMOR TRANSDUCTION WITH THE HERPES-SIMPLEX THYMIDINE KINASE GENE GANCICLOVIR SYSTEM
    RAFFEL, C
    CULVER, K
    KOHN, D
    NELSON, M
    SIEGEL, S
    GILLIS, F
    LINK, CJ
    VILLABLANCA, JG
    ANDERSON, WF
    HUMAN GENE THERAPY, 1994, 5 (07) : 863 - 890
  • [42] A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir
    Shand, N
    Weber, F
    Mariani, L
    Bernstein, M
    Gianella-Borradori, A
    Long, Z
    Sorensen, AG
    Barbier, N
    HUMAN GENE THERAPY, 1999, 10 (14) : 2325 - 2335
  • [43] Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir
    Namba, H
    Tagawa, M
    Miyagawa, T
    Iwadate, Y
    Sakiyama, S
    CANCER GENE THERAPY, 2000, 7 (06) : 947 - 953
  • [44] Herpes simplex virus thymidine kinase gene/ganciclovir gene therapy for primary malignant glioma: Results of a phase III study
    Rainov, NG
    CANCER GENE THERAPY, 2000, 7 (08) : 1208 - 1208
  • [45] Bystander killing of uterine endometrial cancer cells by herpes simplex virus thymidine kinase is mediated by ganciclovir and retinoids
    Suzuki, Takahir
    Matsuura, Motoki
    Tanaka, Ryoichi
    Ito, Eiki
    Ryosaka, Miwa
    Saito, Tsuyoshi
    CANCER RESEARCH, 2009, 69
  • [46] Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma
    Yoshio Sakai
    Shuichi Kaneko
    Yasunari Nakamoto
    Takashi Kagaya
    Naofumi Mukaida
    Kenichi Kobayashi
    Cancer Gene Therapy, 2001, 8 : 695 - 704
  • [47] Human prostate carcinoma cells as targets for herpes simplex virus thymidine kinase-mediated suicide gene therapy
    Loimas, S
    Toppinen, MR
    Visakorpi, T
    Jänne, J
    Wahlfors, J
    CANCER GENE THERAPY, 2001, 8 (02) : 137 - 144
  • [48] Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma
    Sakai, Y
    Kaneko, S
    Nakamoto, Y
    Kagaya, T
    Mukaida, N
    Kobayashi, K
    CANCER GENE THERAPY, 2001, 8 (10) : 695 - 704
  • [49] Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants
    Pantuck, AJ
    Matherly, J
    Zisman, A
    Nguyen, D
    Berger, F
    Gambhir, SS
    Black, ME
    Belldegrun, A
    Wu, LL
    HUMAN GENE THERAPY, 2002, 13 (07) : 777 - 789
  • [50] Contribution of a combination of ponicidin and acyclovir/ganciclovir to the antitumor efficacy of the herpes simplex virus thymidine kinase gene therapy system
    Hayashi, K
    Hayashi, T
    Sun, HD
    Takeda, Y
    HUMAN GENE THERAPY, 2002, 13 (03) : 415 - 423
12345